Show simple item record

dc.contributor.authorMendillo, Marc L.
dc.contributor.authorSantagata, Sandro
dc.contributor.authorBell, George W.
dc.contributor.authorHu, Rong
dc.contributor.authorTamimi, Rulla M.
dc.contributor.authorFraenkel, Ernest
dc.contributor.authorInce, Tan A.
dc.contributor.authorWhitesell, Luke
dc.contributor.authorLindquist, Susan
dc.contributor.authorKoeva, Martina I
dc.date.accessioned2014-11-26T14:02:30Z
dc.date.available2014-11-26T14:02:30Z
dc.date.issued2012-08
dc.date.submitted2012-04
dc.identifier.issn00928674
dc.identifier.issn1097-4172
dc.identifier.urihttp://hdl.handle.net/1721.1/91912
dc.description.abstractHeat-Shock Factor 1 (HSF1), master regulator of the heat-shock response, facilitates malignant transformation, cancer cell survival, and proliferation in model systems. The common assumption is that these effects are mediated through regulation of heat-shock protein (HSP) expression. However, the transcriptional network that HSF1 coordinates directly in malignancy and its relationship to the heat-shock response have never been defined. By comparing cells with high and low malignant potential alongside their nontransformed counterparts, we identify an HSF1-regulated transcriptional program specific to highly malignant cells and distinct from heat shock. Cancer-specific genes in this program support oncogenic processes: cell-cycle regulation, signaling, metabolism, adhesion and translation. HSP genes are integral to this program, however, many are uniquely regulated in malignancy. This HSF1 cancer program is active in breast, colon and lung tumors isolated directly from human patients and is strongly associated with metastasis and death. Thus, HSF1 rewires the transcriptome in tumorigenesis, with prognostic and therapeutic implications.en_US
dc.description.sponsorshipKathy and Curt Marble Cancer Research Funden_US
dc.description.sponsorshipGlaxoSmithKline (WE234 EPI40307)en_US
dc.description.sponsorshipUnited States. Public Health Service (Grant CA087969)en_US
dc.description.sponsorshipNational Cancer Institute (U.S.) (SPORE in Breast Cancer CA089393)en_US
dc.language.isoen_US
dc.publisherElsevieren_US
dc.relation.isversionofhttp://dx.doi.org/10.1016/j.cell.2012.06.031en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourceElsevieren_US
dc.titleHSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancersen_US
dc.typeArticleen_US
dc.identifier.citationMendillo, Marc L., Sandro Santagata, Martina Koeva, George W. Bell, Rong Hu, Rulla M. Tamimi, Ernest Fraenkel, Tan A. Ince, Luke Whitesell, and Susan Lindquist. “HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers.” Cell 150, no. 3 (August 2012): 549–562. © 2012 Elsevier Inc.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.departmentWhitehead Institute for Biomedical Researchen_US
dc.contributor.mitauthorKoeva, Martina I.en_US
dc.contributor.mitauthorFraenkel, Ernesten_US
dc.contributor.mitauthorLindquist, Susanen_US
dc.relation.journalCellen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsMendillo, Marc L.; Santagata, Sandro; Koeva, Martina; Bell, George W.; Hu, Rong; Tamimi, Rulla M.; Fraenkel, Ernest; Ince, Tan A.; Whitesell, Luke; Lindquist, Susanen_US
dc.identifier.orcidhttps://orcid.org/0000-0003-1307-882X
dc.identifier.orcidhttps://orcid.org/0000-0001-9249-8181
dc.identifier.orcidhttps://orcid.org/0000-0001-7024-0921
mit.licensePUBLISHER_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record